Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY:CVS)

75.38 -0.39 (-0.52%)
Streaming Delayed Price Updated: 11:44 AM EDT, Sep 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2 3 4 5 6 7 8 9
...
61 62 Next >
Senate Bill Tightens Medicaid Rules: Humana, Cigna, CVS See Medicare Relief
The draft Senate bill introduces stricter work requirements and funding curbs for Medicaid, while shelving proposed Medicare cuts that could have impacted major insurers. 
Via Stocktwits
Topics Government
3 Stocks With Rising Dividends Investors Shouldn’t Ignore
Via MarketBeat
5 Undervalued Dividend Stocks You Can Buy Now and Hold Long-Term
Via The Motley Fool
Synergy CHC (NASDAQ: SNYR) Taps Coca-Cola Exec to Accelerate Global Expansion of “FOCUSfactor®” Energy Drink – More Stocks Moving Inside
Via AB Newswire
What 10 Analyst Ratings Have To Say About CVS Health
 
Via Benzinga
What Does the Market Think About CVS Health?
 
Via Benzinga
Humana Backs Reforms To Limit Medicare Advantage Billing Practices
Humana is joining lawmakers in support of limiting Medicare Advantage payments tied to home visit diagnoses. 
Via Benzinga
Synergy CHC Corp. (NASDAQ: SNYR) Restructures Debt with $20M Facility to Power Global Growth and FOCUSfactor Beverage Expansion
Via AB Newswire
S&P 500 Earnings Stun The Street In Q1 With Broad-Based Beats, Double-Digit Growth
Nearly 80% of S&P 500 firms beat Q1 earnings forecasts. Profit growth hit 13.3%, led by tech and health care, says FactSet. 
Via Benzinga
Topics Stocks
Amazon Pharmacy Challenges CVS Health And Walgreens Dominance, Unveils New Features To Expand Medicare Access
Amazon Pharmacy introduces caregiver support and expands PillPack access for Medicare users, simplifying medication routines with secure tools and pre-sorted packets. 
Via Benzinga
Top S&P500 movers in Friday's session
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Friday. Discover which stocks are leading as top gainers and losers in today's session. 
Via Chartmill
1 Large-Cap Stock with Exciting Potential and 2 to Think Twice About
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth... 
Via StockStory
Breaking Update: Synergy Corp. (NASDAQ: SNYR) Powers Up FOCUSfactor Expansion – Early Movers Include ALZN, ZEO, NAOV, HTCR
Via AB Newswire
Synergy CHC Corp. (NASDAQ: SNYR) Taps Beverage Veteran to Drive FOCUSfactor’s Drink Expansion – More Stocks Inside
Via AB Newswire
Topics Economy
Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly
Eli Lilly is rapidly encroaching on Novo Nordisk's yearslong lead in GLP-1 drugs. Can Novo hold its tentpole position? 
Via Investor's Business Daily
Q1 Earnings Roundup: Humana (NYSE:HUM) And The Rest Of The Health Insurance Providers Segment
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Humana (NYSE:HUM) and the best and worst... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Synergy CHC Corp. (NASDAQ: SNYR) Powerhouse Brand “FOCUSfactor” Driving Growth
Via AB Newswire
Wednesday's session: top gainers and losers in the S&P500 index
Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
Stay informed with the top movers within the S&P500 index on Wednesday.
Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
"If Walmart Is Under Pressure to Raise Prices, It's Going to Have Broader Effects on the Economy."
Via The Motley Fool
Topics Earnings Economy World Trade
2 Value Stocks with Exciting Potential and 1 to Steer Clear Of
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are... 
Via StockStory
Palantir: The Only Cathie Wood Pick Among S&P 500's Top Performers
NRG Energy Inc leads S&P 500's 2024 leaderboard with 70% YTD gain. Palantir follows with 64% surge, only stock from Cathie Wood's ARK funds in top performers. 
Via Benzinga
Topics Stocks
Benzinga Bulls And Bears: Alphabet, L3Harris, Target — And Latest Tariff News Roils Markets
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
Via Benzinga
What the Options Market Tells Us About CVS Health
 
Via Benzinga
8 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Microsoft Clears Major Hurdle As FTC Ends Effort To Block Activision Merger
The Ninth Circuit affirmed a decision denying the FTC's application to block Microsoft's acquisition of Activision Blizzard. The FTC dropped the case and Trump's personnel changes may impact future... 
Via Benzinga
Topics Government
FTC Scraps PepsiCo Price Discrimination Case In 3-0 Vote, Marking Major Shift As Trump-Era Leadership Reverses Biden Crackdown
The Federal Trade Commission voted 3-0 Thursday to dismiss a lawsuit against PepsiCo Inc. that accused the beverage giant of offering preferential pricing to major retailers, marking a significant... 
Via Benzinga
Topics Government Lawsuit
Which S&P500 stocks are moving before the opening bell on Thursday?
As the US market prepares to open on Thursday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses. 
Via Chartmill
UnitedHealth, CVS Health And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
 
Via Benzinga
Wegovy, Zepbound Just Got Cheaper: Cigna Sets $200 Monthly Limit For Weight-Loss Drug Users
Cigna’s Evernorth has reached agreements with Eli Lilly and Novo Nordisk to reduce prices for GLP-1 weight-loss drugs Wegovy and Zepbound 
Via Stocktwits
< Previous 1 2 3 4 5 6 7 8 9
...
61 62 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.